0
0

CLEAR Act

12/29/2022, 4:48 PM

Congressional Summary of S 4333

Consistent Legal Evaluation And Regulation of Medical Products Act or the CLEAR Act

This bill requires the Food and Drug Administration to regulate contrast agents for medical imaging devices, radioactive drugs, over-the-counter monograph drugs, and ophthalmic drug articles (i.e., eye droppers) as drugs rather than medical devices.

Current Status of Bill S 4333

Bill S 4333 is currently in the status of Bill Introduced since May 26, 2022. Bill S 4333 was introduced during Congress 117 and was introduced to the Senate on May 26, 2022.  Bill S 4333's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of May 26, 2022

Bipartisan Support of Bill S 4333

Total Number of Sponsors
1
Democrat Sponsors
1
Republican Sponsors
0
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
0
Republican Cosponsors
1
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 4333

Primary Policy Focus

Health

Alternate Title(s) of Bill S 4333

CLEAR Act
CLEAR Act
Consistent Legal Evaluation And Regulation of Medical Products Act
A bill to deem certain products regulated by the Food and Drug Administration as drugs.

Comments